Cargando…

Stroke Prophylaxis in Patients with Atrial Fibrillation and End-Stage Renal Disease

Atrial fibrillation (AF) is an important comorbidity in patients with end-stage renal disease (ESRD) undergoing dialysis that portends increased health care utilization, morbidity, and mortality in this already high-risk population. Patients with ESRD have a particularly high stroke risk, which is f...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Zyl, Martin, Abdullah, Hafez M., Noseworthy, Peter A., Siontis, Konstantinos C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019832/ https://www.ncbi.nlm.nih.gov/pubmed/31906546 http://dx.doi.org/10.3390/jcm9010123

Ejemplares similares

Is Atrial Fibrillation Management as Simple as ABC?
por: Yao, Xiaoxi, et al.
Publicado: (2020)

Anticoagulation for Stroke Prevention in Older Adults with Atrial Fibrillation and Comorbidity: Current Evidence and Treatment Challenges
por: Sabbag, Avi, et al.
Publicado: (2018)

Atrial Fibrillation and Cancer: Where Biology and Epidemiology Intertwine
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

On-treatment follow-up in real-world studies of direct oral anticoagulants in atrial fibrillation: Association with treatment effects
por: Hutto, David, et al.
Publicado: (2022)

Atrial fibrillation, end-stage renal disease and hemorrhagic pleural-pericarditis
por: Leonte, Raluca-Mihaela, et al.
Publicado: (2021)

Atrial fibrillation ablation in end-stage renal Disease:...Yes, we can!
por: Kowlgi, Gurukripa N., et al.
Publicado: (2021)

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation)
por: Coll-Vinent, Blanca, et al.
Publicado: (2017)

Anticoagulation for Stroke Prevention of Concomitant Atrial Fibrillation and End-Stage Renal Disease: Insights of Cardiologists and Nephrologists From India
por: ES, Swetha, et al.
Publicado: (2022)

Anticoagulation in Patients with End-Stage Renal Disease and Atrial Fibrillation: Confusion, Concerns and Consequences
por: Goel, Narender, et al.
Publicado: (2020)

Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease
por: Han, Kyung-Do, et al.
Publicado: (2023)

Atrial Fibrillation in Patients with End-stage Kidney Disease on Dialysis
por: Watanabe, Hiroshi, et al.
Publicado: (2018)

Patterns of Anticoagulation Use and Cardioembolic Risk After Catheter Ablation for Atrial Fibrillation
por: Noseworthy, Peter A., et al.
Publicado: (2015)

Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysis
por: Lin, Ting-Tse, et al.
Publicado: (2015)

Association between atrial fibrillation and risk of end-stage renal disease among adults with diabetes mellitus
por: Chang, Yu-Kang, et al.
Publicado: (2022)

Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis
por: Tan, Jingwen, et al.
Publicado: (2016)

Does Atrial Fibrillation Increase the Risk of Developing End-stage Renal Disease in Patients with Chronic Kidney Disease?
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020)

Atrial fibrillation in patients with end‐stage renal disease on hemodialysis: Magnitude of the problem and new approach to oral anticoagulation
por: Königsbrügge, Oliver, et al.
Publicado: (2019)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
por: Sehrawat, Ojasav, et al.
Publicado: (2023)

Challenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A Review
por: Alcocer, Luis
Publicado: (2016)

Peri-procedural anticoagulation in patients with end-stage kidney disease undergoing atrial fibrillation ablation: results from the multicentre end-stage kidney disease–atrial fibrillation ablation registry
por: Yamamoto, Tasuku, et al.
Publicado: (2023)

Inflammasome activation in end‐stage heart failure‐associated atrial fibrillation
por: Kugler, Szilvia, et al.
Publicado: (2022)

Prediction of Atrial Fibrillation Using Machine Learning: A Review
por: Tseng, Andrew S., et al.
Publicado: (2021)

Artificial intelligence-enhanced electrocardiography in cardiovascular disease management
por: Siontis, Konstantinos C., et al.
Publicado: (2021)

Increased risk of atrial fibrillation in end-stage renal disease patients on dialysis: A nationwide, population-based study in Taiwan
por: Shen, Cheng-Huang, et al.
Publicado: (2016)

Rho Kinase Activity, Connexin 40, and Atrial Fibrillation: Mechanistic Insights from End-Stage Renal Disease on Dialysis Patients
por: Calò, Lorenzo A., et al.
Publicado: (2020)

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study
por: Zwartkruis, Victor W, et al.
Publicado: (2021)

Artificial Intelligence for the Detection and Treatment of Atrial Fibrillation
por: Harmon, David M, et al.
Publicado: (2023)

Dialysis Mode and Associated Outcomes in Patients With End‐Stage Renal Disease and Atrial Fibrillation: A 14‐Year Nationwide Cohort Study
por: Chang, Chih‐Hsiang, et al.
Publicado: (2021)

Echocardiographic assessment of left atrial size in patients with end-stage renal disease
por: Koçinaj, Dardan, et al.
Publicado: (2009)

Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
por: Yao, Xiaoxi, et al.
Publicado: (2016)

Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018)

The atrial fibrillation paradox -connecting hypertension to atrial disease and stroke
por: Mendys, Phil, et al.
Publicado: (2021)

Prevalence and associated factors of undiagnosed atrial fibrillation among end-stage renal disease patients on maintenance haemodialysis: a cross-sectional study
por: AlAwwa, Izzat, et al.
Publicado: (2020)

Association Between Use of Warfarin for Atrial Fibrillation and Outcomes Among Patients With End-Stage Renal Disease: A Systematic Review and Meta-analysis
por: Randhawa, Mandeep S., et al.
Publicado: (2020)

Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations
por: Tripathi, Byomesh, et al.
Publicado: (2019)

Prescription of DOACs in Patients with Atrial Fibrillation at Different Stages of Renal Insufficiency
por: Hahn, Kai, et al.
Publicado: (2023)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Prevalence, Clinical Correlations, and Mortality in a Large High‐Risk Population
por: Siontis, Konstantinos C., et al.
Publicado: (2014)

Atrial Fibrosis, Ischaemic Stroke and Atrial Fibrillation
por: Mahnkopf, Christian, et al.
Publicado: (2021)

Pharmacological Prophylaxis of Atrial Fibrillation After Surgical Myocardial Revascularization
por: Osmanovic, Enes, et al.
Publicado: (2019)

Atrial Fibrillation Related and Unrelated Stroke Recurrence Among Ischemic Stroke Patients With Atrial Fibrillation
por: Kim, Bum Joon, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_p17q37eg78430klha8ubspgon5